Literature DB >> 2648135

Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence.

T Yoshimura1, E A Robinson, E Appella, K Matsushima, S D Showalter, A Skeel, E J Leonard.   

Abstract

Human monocyte-derived neutrophil chemotactic factor (MDNCF) was purified from culture supernatant of lipopolysaccharide-stimulated human peripheral blood mononuclear leukocytes on a column of Sepharose-bound murine monoclonal anti-MDNCF. About 65% of the culture fluid chemotactic activity was bound to the column. The unbound 35% probably represents chemotactic activity of other cytokines in the culture fluid. More than 85% of the bound activity was eluted by pH 2.5 glycine buffer. When this material was applied to an HPLC-CM column, gradient elution produced four well-separated A280 peaks, each of which had chemotactic activity. N-terminal amino acid analysis of the four peaks revealed three different sequences. One (MDNCF-c) was identical to the sequence that we reported previously. The other two (MDNCF-a and -b) had seven and five additional amino acids, respectively, at the N-terminus. MDNCF-a, -b and -c accounted for 8, 47 and 45% of the total MDNCF peptide. Alignment with the MDNCF cDNA sequence shows that MDNCF-a results from cleavage of a 20 residue signal peptide. MDNCF-c results from culture fluid proteolytic cleavage of the N-terminal sequences of MDNCF-a and -b at an R-S bond. The three peptides occurred in the four HPLC-CM peaks in different ratios. The bulk of any one peptide was distributed in two adjacent HPLC-CM peaks. This suggests that each peptide exists in a minimum of two states. In contrast to our previous multi-step purification, the immunoaffinity and HPLC-CM column sequence resulted in complete purification of MDNCF in two steps and led to identification of two additional MDNCF peptides, one of which has not heretofore been detected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648135     DOI: 10.1016/0161-5890(89)90024-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  16 in total

1.  Expression of IL-8 in Kawasaki disease.

Authors:  T Asano; S Ogawa
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  The role of CD18 in IL-8 induced dermal and synovial inflammation.

Authors:  M J Forrest; G J Eiermann; R Meurer; L A Walakovits; D E MacIntyre
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

4.  Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum.

Authors:  I Sylvester; T Yoshimura; M Sticherling; J M Schröder; M Ceska; P Peichl; E J Leonard
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  A novel neutrophil chemoattractant generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo. Purification, partial amino acid sequence and structural relationship to interleukin 8.

Authors:  B C Beaubien; P D Collins; P J Jose; N F Totty; J Hsuan; M D Waterfield; T J Williams
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

Review 6.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

7.  Developmental changes in circulating IL-8/CXCL8 isoforms in neonates.

Authors:  Akhil Maheshwari; Nikolai N Voitenok; Svetlana Akalovich; Sadiq S Shaik; David A Randolph; Brian Sims; Rakesh P Patel; Cheryl R Killingsworth; Michael B Fallon; Robin K Ohls
Journal:  Cytokine       Date:  2009-02-15       Impact factor: 3.861

8.  Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain.

Authors:  Ji Zhang; Xiang Qun Shi; Stefania Echeverry; Jeffrey S Mogil; Yves De Koninck; Serge Rivest
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

9.  Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.

Authors:  Teresa G D'Aversa; Karl O A Yu; Joan W Berman
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

10.  CCL2 in the Tumor Microenvironment.

Authors:  Tracy O'Connor; Mathias Heikenwalder
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.